The anatomy of a corporate transaction in the United States has fundamentally changed. What was once a relatively contained exercise in financial modeling, standard regulatory compliance, and contract negotiation has morphed into a multi-dimensional chess game. Today, every major deal is shadowed by global supply chain vulnerabilities, emerging technology regulations, and the ever-present threat of reputational damage. For US law professionals, the mandate is clear: the modern transactional attorney can no longer just close the deal; they must holistically insulate the enterprise.
Two recent developments in the US legal market perfectly encapsulate this shifting paradigm. First, Foley & Lardner LLP’s strategic expansion in New York with the addition of Partner Heather Miles to its Transactions Practice Group, specifically targeting the convergence of innovative technology and healthcare. Second, a timely warning from Latham & Watkins detailing the intense geopolitical and reputational considerations currently keeping General Counsels awake at night.
Together, these moves signal a broader market recalibration. Big Law is actively rewiring its corporate practices to meet the demands of an era where global risk and technological disruption sit at the very center of the deal table.
The Strategic Arms Race in Specialized Transactions
The addition of Heather Miles to Foley & Lardner's New York office is not merely a routine lateral hire; it is a calculated strike in the ongoing battle for dominance in highly regulated, high-growth sectors. By focusing her practice on innovative technology and healthcare, Foley is addressing the two industries most heavily impacted by modern regulatory scrutiny and macro-economic shifts.
Why Tech and Healthcare?
The boundary between technology and healthcare has effectively collapsed. From AI-driven diagnostics to telemedicine platforms and biometric data monetization, the modern healthcare transaction is fundamentally a technology transaction. This convergence requires a new breed of legal advisor.
- Data Sovereignty and Privacy: Health-tech deals now require exhaustive diligence into how data is collected, stored, and transferred across borders, heavily implicating both HIPAA in the US and international frameworks like GDPR.
- AI and Algorithmic Liability: Acquiring a health-tech startup increasingly means acquiring its algorithms. Assessing the legal risk of AI bias or diagnostic failure is now a critical component of M&A diligence.
- Regulatory Agility: The FDA and FTC are rapidly evolving their stances on digital health and tech consolidation, requiring transactional partners to possess deep, predictive regulatory foresight.
Foley’s move to bolster this specific expertise in New York—the epicenter of global capital markets—demonstrates that law firms are moving away from generalist corporate models toward highly specialized, industry-fluent transaction teams.
The Latham Warning: Geopolitics at the Deal Table
While firms like Foley are building out specialized industry capabilities, the macro environment in which these deals operate has grown increasingly hostile. Latham & Watkins recently highlighted a critical evolution in the role of the General Counsel: the necessity of navigating complex geopolitical and reputational risks.
"The role of the GC has expanded far beyond traditional legal risk management. Today's chief legal officers are expected to be strategic advisors on global volatility, navigating the intricate web of economic sanctions, supply chain disruptions, and the rapid politicization of corporate behavior."
This reality fundamentally alters the transactional landscape. A tech or healthcare acquisition that makes perfect financial sense might be a geopolitical landmine. For instance, acquiring a medical device manufacturer with critical components sourced from politically sensitive regions introduces existential supply chain risks. Similarly, foreign direct investment in US technology is facing unprecedented scrutiny from the Committee on Foreign Investment in the United States (CFIUS).
The Reputational Premium
Furthermore, Latham's insights underscore the rising premium on reputational capital. In an era of hyper-connected stakeholder activism, the reputational fallout of a misaligned transaction can erase shareholder value overnight. GCs are now demanding that their outside counsel evaluate deals not just for legal compliance, but for "headline risk."
The New Due Diligence Paradigm
The synthesis of Foley's sector-specific expansion and Latham's geopolitical warnings reveals a profound shift in how due diligence must be conducted in 2026. The traditional checklists are no longer sufficient. Law firms must adopt a "Risk-Adjusted" due diligence framework.
| Diligence Category | Traditional Approach | Modern "Risk-Adjusted" Approach |
|---|---|---|
| Regulatory | Standard antitrust and domestic compliance (e.g., SEC, FTC). | CFIUS scrutiny, export controls, and international sanctions mapping. |
| Technology/IP | Patent ownership, trademark registration, and open-source licenses. | AI algorithmic bias, data sovereignty, and cross-border data transfer risks. |
| Operations | Contract review, employment agreements, and real estate leases. | Supply chain vulnerability, geopolitical exposure of key vendors. |
| Corporate PR | Drafting the press release and managing investor communications. | Stakeholder activism risk assessment and ESG/DEI liability profiling. |
Actionable Imperatives for US Legal Professionals
For law firm partners, associates, and in-house counsel, this evolving landscape demands an immediate recalibration of skills and strategies.
- Integrate Geopolitical Risk into Standard Workflows: Law firms must stop treating geopolitical risk as an "exotic" issue reserved for international trade specialists. Corporate associates must be trained to identify supply chain and foreign investment red flags at the earliest stages of the term sheet.
- Deepen Sector Fluency: As Foley's hiring strategy demonstrates, clients are paying for deep industry knowledge, not just legal mechanics. Transactional attorneys must become fluent in the operational and technological realities of the sectors they serve—particularly where tech intersects with heavily regulated fields like healthcare or finance.
- Elevate the GC Partnership: Outside counsel must proactively help GCs manage the board of directors. This means providing clear, executive-level briefings on how a proposed transaction impacts the company's broader reputational and geopolitical risk profile, echoing the guidance from Latham & Watkins.
- Leverage AI for Macro-Diligence: The sheer volume of data required to assess global risk is beyond human capacity. Firms must deploy advanced legal AI to monitor real-time changes in sanctions, supply chain disruptions, and global regulatory shifts during the lifecycle of a deal.
Looking Ahead: The Future of the Corporate Practice
The expansion of Foley & Lardner’s transactions team in New York and the strategic warnings from Latham & Watkins are not isolated events; they are the blueprint for the future of Big Law corporate practices. The most successful firms over the next decade will be those that seamlessly blend elite transactional execution with deep geopolitical foresight and technological fluency.
For General Counsels navigating an increasingly fractured global market, the definition of "good counsel" has permanently changed. They no longer just need lawyers who can paper a deal; they need strategic partners who can see around corners, anticipate global shockwaves, and engineer transactions that are as resilient as they are profitable. In this new era, mitigating global risk isn't just a part of the deal—it is the deal.